NDC Compounded Drug 73702-141-32 Naloxone Hydrochloride
Liquid Oral
Compounded Drug Product Information
| NDC Product Code | 73702-141 |
| NDC Package Code | 73702-141-32 |
| 11-Digit NDC Billing Format NDC Format for Billing For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration. |
73702014132 |
| Package Description | 2 mL in 1 SYRINGE, PLASTIC |
| Product Type What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing. |
Human Compounded Drug |
| Proprietary Name What is the Proprietary Name? The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes. |
Naloxone Hcl |
| Non-Proprietary Name What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product. |
Naloxone |
| Substance Name What is the Substance Name? An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted. |
Naloxone Hydrochloride |
| Usage Information Product Usage Information The drug use information is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate. This information is not individual medical advice and does not substitute for the advice of a health care professional. Always ask a health care professional for complete information about this product and your specific health needs. |
This medication is used to treat known or suspected opioid overdose. Serious overdose symptoms may include unusual sleepiness, unusual difficulty waking up, or breathing problems (ranging from slow/shallow breathing to no breathing). Other symptoms of overdose may include very small "pinpoint" pupils, slow heartbeat, or low blood pressure. If someone has serious overdose symptoms but you are not sure if he or she has overdosed, give this medication right away anyway, since lasting slow/shallow breathing may cause permanent damage to the brain or death. Naloxone belongs to a class of drugs known as opioid antagonists. It works by blocking the effects of the opioid in the brain. This medication may not work as well to block the effects of certain types of opioids (mixed agonist/antagonists such as buprenorphine, pentazocine). With these types of opioids, blocking may be incomplete or you may need a higher dose of naloxone. Treatment of opioid overdose should also include breathing treatment (such as oxygen given through tubes in the nose, mechanical ventilation, artificial respiration). |
| Dosage Form | Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions. |
| Route Name | Oral - Administration to or by way of the mouth. |
| Marketing Category | OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) |
| Labeler Code | 73702 |
| Labeler Name What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC. |
Wells Pharma Of Houston |
| Substance Name | Naloxone Hydrochloride |
| Active Ingredients Information | 1 mg/1 mL |
| Reporting Period | 2023-1 |
Frequently Asked Questions
What is the NDC number assigned to Naloxone Hcl?
Naloxone Hcl was assigned by its manufacturer with NDC product code 73702-141. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Naloxone Hcl?
The NDC package code 73702-141-32 was assigned to a 2 mL in 1 SYRINGE, PLASTIC of naloxone hydrochloride administered oral via liquid.
Who manufactures this product?
Naloxone Hcl is manufactured by an outsourced facility and labeled by Wells Pharma Of Houston. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
